Follow Us
India permits clinical trial for nasal Covid booster shot
The central licensing authority (Drug Controller General of India) granted the permission for the world’s first nasal Covid shot as a booster
Aditi Tandon
New Delhi, January 28
India on Friday cleared Bharat Biotech’s intranasal Covid vaccine candidate for clinical trials as Covid booster dose.
The central licensing authority (Drug Controller General of India) granted the permission for the world’s first nasal Covid shot as a booster.
Once approved, this could be a game changer, sources said, citing the ease of vaccine delivery.
The permission to conduct clinical trials has been given for nine sites across India, including Pt BD Sharma Postgraduate Institute of Medical Sciences (PGIMS), UHS, Rothak, Haryana, AIIMS New Delhi and AIIMS Patna.
The candidate cleared for trials is Chimpanzee Adenovirus Vectored Covid Vaccine (BBV154).
The Tribune News Service brings you the latest news, analysis and insights from the region, India and around the world. Follow the Tribune News Service for a wide-ranging coverage of events as they unfold, with perspective and clarity.
Join Whatsapp Channel of The Tribune for latest updates.
Show comments
Show comments
Trending News
Also In This Section
Top News
Most Read In 24 Hours
8
9